
Derek Douglas Knight
Examiner (ID: 5703, Phone: (571)272-7951 , Office: P/3659 )
| Most Active Art Unit | 3659 |
| Art Unit(s) | 3659, 3655, 3681 |
| Total Applications | 1137 |
| Issued Applications | 957 |
| Pending Applications | 48 |
| Abandoned Applications | 155 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9055199
[patent_doc_number] => 20130252913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-26
[patent_title] => '18-Membered Macrocycles and Analogs Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/838634
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10241
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13838634
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/838634 | 18-Membered Macrocycles and Analogs Thereof | Mar 14, 2013 | Abandoned |
Array
(
[id] => 10331774
[patent_doc_number] => 20150216778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'Method for Preparing 3,6-Anhydro-L-Galactose, And Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/373274
[patent_app_country] => US
[patent_app_date] => 2013-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9263
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14373274
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/373274 | Method for Preparing 3,6-Anhydro-L-Galactose, And Use Thereof | Jan 17, 2013 | Abandoned |
Array
(
[id] => 10926745
[patent_doc_number] => 20140329766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-06
[patent_title] => 'Prophylactic Compositions for Management of Microbial Infections in Patients with Brain Injury'
[patent_app_type] => utility
[patent_app_number] => 14/361030
[patent_app_country] => US
[patent_app_date] => 2012-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 64
[patent_figures_cnt] => 64
[patent_no_of_words] => 15768
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14361030
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/361030 | Prophylactic Compositions for Management of Microbial Infections in Patients with Brain Injury | Nov 27, 2012 | Abandoned |
Array
(
[id] => 8612869
[patent_doc_number] => 20130018181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-17
[patent_title] => 'Novel and Highly Stereoselective Process for Preparing Gemcitabine and Intermediates Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/622264
[patent_app_country] => US
[patent_app_date] => 2012-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6249
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13622264
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/622264 | Novel and Highly Stereoselective Process for Preparing Gemcitabine and Intermediates Thereof | Sep 17, 2012 | Abandoned |
Array
(
[id] => 9772513
[patent_doc_number] => 20140296176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'COMBINATION CANCER THERAPY WITH AN HSP90 INHIBITOR AND AN ANTIMETABOLITE'
[patent_app_type] => utility
[patent_app_number] => 14/239676
[patent_app_country] => US
[patent_app_date] => 2012-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 17966
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14239676
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/239676 | COMBINATION CANCER THERAPY WITH AN HSP90 INHIBITOR AND AN ANTIMETABOLITE | Aug 16, 2012 | Abandoned |
Array
(
[id] => 8483839
[patent_doc_number] => 20120283246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-08
[patent_title] => 'NOVEL PARENTERAL CARBAMAZEPINE FORMULATION'
[patent_app_type] => utility
[patent_app_number] => 13/547866
[patent_app_country] => US
[patent_app_date] => 2012-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8771
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13547866
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/547866 | Parenteral carbamazepine formulation | Jul 11, 2012 | Issued |
Array
(
[id] => 8866610
[patent_doc_number] => 20130150312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-13
[patent_title] => 'TOPICAL ANTIVIRAL FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 13/523471
[patent_app_country] => US
[patent_app_date] => 2012-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10948
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13523471
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/523471 | TOPICAL ANTIVIRAL FORMULATIONS | Jun 13, 2012 | Abandoned |
Array
(
[id] => 8324413
[patent_doc_number] => 20120196812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-02
[patent_title] => 'PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/439324
[patent_app_country] => US
[patent_app_date] => 2012-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 21022
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13439324
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/439324 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | Apr 3, 2012 | Abandoned |
Array
(
[id] => 9263229
[patent_doc_number] => 20130345159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'PURIFIED CARDIOGENIN ISOMER AND RELATED METHODS'
[patent_app_type] => utility
[patent_app_number] => 13/996446
[patent_app_country] => US
[patent_app_date] => 2011-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 7211
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13996446
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/996446 | PURIFIED CARDIOGENIN ISOMER AND RELATED METHODS | Dec 20, 2011 | Abandoned |
Array
(
[id] => 8977325
[patent_doc_number] => 20130210755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-15
[patent_title] => 'METHODS FOR INHIBITING INSECT INFESTATIONS'
[patent_app_type] => utility
[patent_app_number] => 13/879082
[patent_app_country] => US
[patent_app_date] => 2011-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3864
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13879082
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/879082 | METHODS FOR INHIBITING INSECT INFESTATIONS | Nov 6, 2011 | Abandoned |
Array
(
[id] => 7651834
[patent_doc_number] => 20110301103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'Methods of Treatment'
[patent_app_type] => utility
[patent_app_number] => 13/152169
[patent_app_country] => US
[patent_app_date] => 2011-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 16689
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0301/20110301103.pdf
[firstpage_image] =>[orig_patent_app_number] => 13152169
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/152169 | Methods of Treatment | Jun 1, 2011 | Abandoned |
Array
(
[id] => 7487492
[patent_doc_number] => 20110251148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-13
[patent_title] => 'GLYCOMIMETIC COMPOUNDS AND METHODS TO INHIBIT INFECTION BY HIV'
[patent_app_type] => utility
[patent_app_number] => 13/081068
[patent_app_country] => US
[patent_app_date] => 2011-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8383
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0251/20110251148.pdf
[firstpage_image] =>[orig_patent_app_number] => 13081068
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/081068 | GLYCOMIMETIC COMPOUNDS AND METHODS TO INHIBIT INFECTION BY HIV | Apr 5, 2011 | Abandoned |
Array
(
[id] => 8043375
[patent_doc_number] => 20120071431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-22
[patent_title] => 'Platycodin Radix Extracts, and Their Use in Treating Disease Conditions Associated with Angiogenesis'
[patent_app_type] => utility
[patent_app_number] => 13/073135
[patent_app_country] => US
[patent_app_date] => 2011-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6992
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20120071431.pdf
[firstpage_image] =>[orig_patent_app_number] => 13073135
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/073135 | Platycodin Radix Extracts, and Their Use in Treating Disease Conditions Associated with Angiogenesis | Mar 27, 2011 | Abandoned |
Array
(
[id] => 6048510
[patent_doc_number] => 20110207693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-25
[patent_title] => 'Oral B12 Therapy'
[patent_app_type] => utility
[patent_app_number] => 13/033118
[patent_app_country] => US
[patent_app_date] => 2011-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9703
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20110207693.pdf
[firstpage_image] =>[orig_patent_app_number] => 13033118
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/033118 | Oral B12 Therapy | Feb 22, 2011 | Abandoned |
Array
(
[id] => 8951153
[patent_doc_number] => 20130196934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'COMPOSITION FOR PERINATAL AND NEONATAL STROKE'
[patent_app_type] => utility
[patent_app_number] => 13/574185
[patent_app_country] => US
[patent_app_date] => 2011-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7677
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13574185
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/574185 | COMPOSITION FOR PERINATAL AND NEONATAL STROKE | Jan 20, 2011 | Abandoned |
Array
(
[id] => 7808007
[patent_doc_number] => 20120058961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'Pharmaceutical Composition for Treating Cancers'
[patent_app_type] => utility
[patent_app_number] => 12/877380
[patent_app_country] => US
[patent_app_date] => 2010-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3814
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20120058961.pdf
[firstpage_image] =>[orig_patent_app_number] => 12877380
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/877380 | Pharmaceutical Composition for Treating Cancers | Sep 7, 2010 | Abandoned |
Array
(
[id] => 6575329
[patent_doc_number] => 20100273733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-28
[patent_title] => 'HIV Treatment'
[patent_app_type] => utility
[patent_app_number] => 12/755558
[patent_app_country] => US
[patent_app_date] => 2010-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3442
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0273/20100273733.pdf
[firstpage_image] =>[orig_patent_app_number] => 12755558
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/755558 | HIV Treatment | Apr 6, 2010 | Abandoned |
Array
(
[id] => 6071225
[patent_doc_number] => 20110046076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/703988
[patent_app_country] => US
[patent_app_date] => 2010-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 24763
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20110046076.pdf
[firstpage_image] =>[orig_patent_app_number] => 12703988
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/703988 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | Feb 10, 2010 | Abandoned |
Array
(
[id] => 6377774
[patent_doc_number] => 20100081629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-01
[patent_title] => 'LOW MOLECULAR WEIGHT HEPARINS INCLUDING AT LEAST ONE COVALENT BOND WITH BIOTIN OR A BIOTIN DERIVATIVE, METHOD FOR MAKING SAME AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/539224
[patent_app_country] => US
[patent_app_date] => 2009-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8365
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20100081629.pdf
[firstpage_image] =>[orig_patent_app_number] => 12539224
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/539224 | LOW MOLECULAR WEIGHT HEPARINS INCLUDING AT LEAST ONE COVALENT BOND WITH BIOTIN OR A BIOTIN DERIVATIVE, METHOD FOR MAKING SAME AND USE THEREOF | Aug 10, 2009 | Abandoned |
Array
(
[id] => 6597770
[patent_doc_number] => 20100292191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'Alkylene Oxide Adducts of Oligosaccharides'
[patent_app_type] => utility
[patent_app_number] => 12/809894
[patent_app_country] => US
[patent_app_date] => 2008-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5147
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20100292191.pdf
[firstpage_image] =>[orig_patent_app_number] => 12809894
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/809894 | Alkylene Oxide Adducts of Oligosaccharides | Dec 10, 2008 | Abandoned |